Search research articles
Contact Us
Filters
Showing results (161-170 of 687) with videos related to
Page
of 69
Sort By:
Cardiovascular Drugs and Therapy
|
November 9, 2021
The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus
Bertram Pitt, Gabriel Steg, Lawrence A Leiter, et al.
Cardiovascular Drugs and Therapy
|
January 10, 2022
Response to the Letter on "The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus"
Bertram Pitt, Gabriel Steg, Lawrence A Leiter, et al.
American Heart Journal
|
June 24, 2010
Maximizing scientific knowledge from randomized clinical trials
Finn Gustafsson, Dan Atar, Bertram Pitt, et al.
The New England Journal of Medicine
|
April 5, 2016
Challenges to Data Monitoring Committees When Regulatory Authorities Intervene
Karl Swedberg, Jeffrey S Borer, Bertram Pitt, et al.
Progress in Cardiovascular Diseases
|
April 11, 2025
Incremental benefits of combined inhibition of SGLT1 and SGLT2 with sotagliflozin
Ram D Bhatt, Bertram Pitt, Ph Gabriel Steg, et al.
European Heart Journal
|
October 24, 2018
Association between renin-angiotensin system inhibitor use and mortality/morbidity in elderly patients with heart failure with reduced ejection fraction: a prospective propensity score-matched cohort study
Gianluigi Savarese, Ulf Dahlström, Peter Vasko, et al.
Clinical Cardiology
|
September 5, 2019
Eplerenone in patients with myocardial infarction and "mid-range" ejection fraction: An analysis from the EPHESUS trial
João Pedro Ferreira, Xavier Rossello, Bertram Pitt, et al.
The American Journal of Cardiology
|
February 28, 2002
Effect of losartan in aging-related endothelial impairment
Sanjay Rajagopalan, Robert Brook, Rajendra H Mehta, et al.
Circulation
|
October 1, 2008
Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS)
Bertram Pitt, George Bakris, Luis M Ruilope, et al.
Clinical Kidney Journal
|
April 4, 2022
Influence of race in the estimation of glomerular filtration rate in patients with a high cardiovascular and renal risk
João Pedro Ferreira, Faiez Zannad, Scott D Solomon, et al.
Page
of 69
Search research articles
Search
Showing results (161-170 of 687) with videos related to
Sort By:
Page
of 69
Cardiovascular Drugs and Therapy
|
November 9, 2021
The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus
Bertram Pitt, Gabriel Steg, Lawrence A Leiter, et al.
Cardiovascular Drugs and Therapy
|
January 10, 2022
Response to the Letter on "The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus"
Bertram Pitt, Gabriel Steg, Lawrence A Leiter, et al.
American Heart Journal
|
June 24, 2010
Maximizing scientific knowledge from randomized clinical trials
Finn Gustafsson, Dan Atar, Bertram Pitt, et al.
The New England Journal of Medicine
|
April 5, 2016
Challenges to Data Monitoring Committees When Regulatory Authorities Intervene
Karl Swedberg, Jeffrey S Borer, Bertram Pitt, et al.
Progress in Cardiovascular Diseases
|
April 11, 2025
Incremental benefits of combined inhibition of SGLT1 and SGLT2 with sotagliflozin
Ram D Bhatt, Bertram Pitt, Ph Gabriel Steg, et al.
European Heart Journal
|
October 24, 2018
Association between renin-angiotensin system inhibitor use and mortality/morbidity in elderly patients with heart failure with reduced ejection fraction: a prospective propensity score-matched cohort study
Gianluigi Savarese, Ulf Dahlström, Peter Vasko, et al.
Clinical Cardiology
|
September 5, 2019
Eplerenone in patients with myocardial infarction and "mid-range" ejection fraction: An analysis from the EPHESUS trial
João Pedro Ferreira, Xavier Rossello, Bertram Pitt, et al.
The American Journal of Cardiology
|
February 28, 2002
Effect of losartan in aging-related endothelial impairment
Sanjay Rajagopalan, Robert Brook, Rajendra H Mehta, et al.
Circulation
|
October 1, 2008
Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS)
Bertram Pitt, George Bakris, Luis M Ruilope, et al.
Clinical Kidney Journal
|
April 4, 2022
Influence of race in the estimation of glomerular filtration rate in patients with a high cardiovascular and renal risk
João Pedro Ferreira, Faiez Zannad, Scott D Solomon, et al.
Page
of 69